Alzheimer’s in the Blood

Researchers are on a mission to identify blood-borne biomarkers for dementia. Will this year’s high-profile successes pave the way?

In a study appearing this month (July 8) in Alzheimer’s & Dementia, Simon Lovestone of King’s College London and University of Oxford and his colleagues  published on a panel of 10 proteins that could predict progression from  mild cognitive impairment (MCI) to full-blown Alzheimer’s with a  reported accuracy of 87 percent (calculated as the total number of true results, both positives and negatives, over the total number of tests given).

Read more:
Alzheimer’s in the Blood 

Source: The Scientist Magazine®